Skip to main content
. 2022 Jan;10(2):109. doi: 10.21037/atm-21-4222

Figure 2.

Figure 2

Genes regulated by HIF-1α and their effects on cancer progression. HIF-1α, hypoxia-inducible factor-1 alpha; EPO, erythropoietin; TGF-β3, transforming growth factor β3; VEGF, vascular endothelial growth factor; NOS, nitric oxide synthase; TGF-α, transforming growth factor α; C-MYC, myelocytomatosis virus oncogene cellular homolog; iNOS, inducible nitric oxide synthase; HO-1, heme oxygenase-1; ID2, DNA-binding protein inhibitor; IGF-2, insulin-like growth factor 2; IGF-BP 1/2/3, IGF-binding protein 1/2/3; ADM, adrenomedullin; FN1, fibronectin 1; LOXL2, lysyl oxidase-like 2; uPAR, urokinase plasminogen activator receptor; FLT-1, VEGF receptor FLT-1; TIE-2, tyrosine kinase with immunoglobulin and EGF-like domains 2; PAI-1, plasminogen activator inhibitor 1; EGF, epidermal growth factor; TIMP-1, tissue inhibitor of metalloprotease-1; ANGPT, angiopoietin; LEP, leptin; LRP1, LDL-receptor-related protein 1; Bcl-2, B-cell lymphoma 2; NIP3, nonimprinted polymer 3.